Notice2024-28558
Public Comment Request: Request for Information Regarding HRSA Sickle Cell Disease Programs
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 6, 2024
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
HRSA's Maternal and Child Health Bureau Sickle Cell Disease (SCD) Programs are requesting input from the public to inform future SCD program development.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 235 (Friday, December 6, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 235 (Friday, December 6, 2024)]
[Notices]
[Pages 97013-97014]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-28558]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Public Comment Request: Request for Information Regarding HRSA
Sickle Cell Disease Programs
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice of request for public comment.
-----------------------------------------------------------------------
SUMMARY: HRSA's Maternal and Child Health Bureau Sickle Cell Disease
(SCD) Programs are requesting input from the public to inform future
SCD program development.
DATES: Submit comments no later than January 6, 2025.
ADDRESSES: Submit electronic comments to <a href="/cdn-cgi/l/email-protection#592a3a3d292b363e2b38342a19312b2a38773e362f"><span class="__cf_email__" data-cfemail="bfccdcdbcfcdd0d8cdded2ccffd7cdccde91d8d0c9">[email protected]</span></a>. Please
submit your response only one time.
FOR FURTHER INFORMATION CONTACT: Oriana Sanchez, Public Health Analyst,
Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, Rockville,
Maryland 20857; <a href="/cdn-cgi/l/email-protection#d7a4b4b3a7a5b8b0a5b6baa497bfa5a4b6f9b0b8a1"><span class="__cf_email__" data-cfemail="f586969185879a9287949886b59d878694db929a83">[email protected]</span></a> or call (347) 415-1458.
SUPPLEMENTARY INFORMATION: SCD is a group of inherited red blood cell
disorders affecting an estimated 100,000 individuals in the United
States. The Centers for Disease Control and Prevention report that SCD
is a lifelong condition disproportionately affecting Black (1 of every
365 births) and Hispanic Americans (1 of every 16,300 births) with
cases also occurring in individuals of Mediterranean, Middle Eastern,
and Asian descent. SCD causes the body to produce red blood cells that
are crescent shaped which impedes blood flow and cause anemia, severe
pain, organ damage and other complications. Without access to
comprehensive and routine services, life expectancy is greatly reduced
for individuals with SCD. HRSA currently funds a portfolio of three
coordinated programs with several recipients to improve outcomes of
individuals with SCD and their families: the SCD Newborn Screening
Follow-up Program (authorized by 42 U.S.C. 701(a)(2) (sec. 501(a)(2) of
the Social Security Act)) funds 25 community-based organizations, the
SCD Treatment Demonstration Program (authorized by 42 U.S.C. 300b-5(b)
(sec. 1106(b) of the Public Health Service Act)) funds five regional
organizations, and one Hemoglobinopathies National Coordinating Center
(authorized by 42 U.S.C. 300b-5(b) (sec. 1106(b) of the Public Health
Service Act).
Together the programs strengthen the SCD system of care and support
by (1) educating patients, families, and clinicians to improve
knowledge and capacities; (2) linking individuals and families to
evidence-based care; and (3) fostering partnerships between clinicians,
community organizations, and other stakeholders to improve the ability
to deliver coordinated, comprehensive care across the lifespan. HRSA's
SCD portfolio seeks to support and strengthen regional networks of SCD
care, education, and social services across the United States. More
information about the HRSA SCD programs is available online at: <a href="https://mchb.hrsa.gov/programs-impact/programs/sickle-cell">https://mchb.hrsa.gov/programs-impact/programs/sickle-cell</a>.
Responses
HRSA is seeking responses that address the following questions. A
response to each question is not required. When drafting responses,
highlight strategies that HRSA should consider or prioritize to meet
the needs of individuals with SCD and their families within the United
States.
[[Page 97014]]
1. What are the best ways to improve the quality of life of
individuals living with SCD?
2. What strategies or best practices are needed to ensure
individuals with SCD receive comprehensive evidence-based health care?
If possible, describe different strategies needed for children and for
adults in both healthcare (e.g., clinics, hospitals) and non-healthcare
settings (e.g., education, housing, transportation).
3. What are the barriers to ensuring infants identified with SCD
through newborn screening are receiving appropriate follow-up care?
What strategies or practices best address these barriers?
4. What are the barriers to successful transition from pediatric to
adult serving systems? What strategies are available for individuals
with SCD to receive evidence-based, comprehensive care as they
transition into adulthood (e.g., in clinics, hospitals)? What
strategies or programs (e.g., community health worker programs) have
successfully transitioned individuals with SCD in non-health settings
(e.g., education, employment, and living situations)?
5. What are the challenges to improving the systems of care that
support individuals with SCD and their families across the lifespan
more broadly? Please share strategies that can bridge the gaps between
systems that address healthcare (e.g., clinics, hospitals) and systems
that address social determinants of health (e.g., education, housing,
transportation)?
Respondents can also provide additional comments or recommendations
that are not specifically linked to the questions above. All responses
may, but are not required to, identify the individual's name, address,
email, telephone number, professional or organizational affiliation,
background or area of expertise (e.g., program participant, family
member, clinician, public health worker, researcher, HRSA SCD grantee),
and topic/subject matter. Information obtained as a result of this
request for information (RFI) may be used by HRSA for program planning.
Comments in response to this RFI may be made publicly available, so
respondents should bear this in mind when making comments. HRSA will
not respond to any individual comments.
Special Note to Commenters
Whenever possible, respondents are asked to draw their responses
from objective, empirical, and actionable evidence and to cite this
evidence within their responses. The information obtained through this
RFI may help inform the next iteration of the HRSA SCD portfolio of
investments. This RFI is issued solely for information and planning
purposes; it does not constitute a Request for Proposal, applications,
proposal abstracts, or quotations. This RFI does not commit the U.S.
Government to contract for any supplies or services or make a grant or
cooperative agreement award. Further, HRSA is not seeking proposals
through this RFI and will not accept unsolicited proposals. HRSA will
not respond to questions about the policy issues raised in this RFI.
Responders are advised that the U.S. Government will not pay for any
information or administrative costs incurred in response to this RFI;
all costs associated with responding to this RFI will be solely at the
interested party's expense. Not responding to this RFI does not
preclude participation in any future procurement or program, if
conducted.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-28558 Filed 12-5-24; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 6, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.